Alternative splicing expands transcriptome complexity by allowing a single gene to generate multiple RNA isoforms, influencing protein diversity, cellular identity, disease mechanisms, and regulatory programs.
Alternative splicing is a central mechanism of transcriptomic regulation. By selectively including or excluding exons and splice sites, cells can generate multiple RNA transcripts from a single gene, expanding functional diversity without changing the underlying DNA sequence.
At PanorOmics, alternative splicing is presented as a major transcriptomic research area: a regulatory layer connecting RNA processing, gene expression, isoform biology, cancer mechanisms, neurological disease, therapeutic discovery, and multi-omics interpretation.
Identifying alternative transcript isoforms generated from the same gene through different exon combinations and splice junctions.
Studying abnormal splicing events linked to cancer, inherited disease, neurological disorders, and therapeutic resistance.
Analyzing how RNA-binding proteins, splice factors, sequence motifs, and regulatory networks control transcript processing.
Using splice variants and isoform signatures to support diagnosis, prognosis, disease classification, and precision medicine research.
Sequencing-based transcriptome profiling used to detect splice junctions, exon usage, and alternative transcript structures.
Full-length transcript sequencing that improves isoform discovery and resolves complex alternative splicing patterns.
Single-cell transcriptomics used to study cell-type-specific splicing variation and transcriptional heterogeneity.
Targeted experimental validation of specific splice junctions, exon inclusion events, and isoform expression.
Bioinformatic methods that quantify exon usage, splice junctions, isoform abundance, and differential splicing events.
An exon is excluded from the mature RNA transcript, producing an alternative protein or regulatory isoform.
An intron remains in the mature RNA transcript, often influencing RNA stability, translation, or degradation.
Different donor splice sites generate transcript isoforms with altered exon boundaries.
Different acceptor splice sites produce transcript isoforms with variable exon structure.
Only one of two alternative exons is included in the mature transcript.
The relative abundance of transcript isoforms changes across tissues, diseases, treatments, or cell states.
Related transcriptomic approaches such as RNA expression, RNA sequencing, and non-coding RNA analysis are explored across the Transcriptomics Research Center.
The discovery of split genes revealed that RNA transcripts can be processed by removing introns and joining exons.
Alternative splicing became recognized as a major mechanism that allows one gene to produce multiple RNA and protein isoforms.
Genome and transcriptome studies expanded the catalog of splice isoforms across tissues, organisms, and disease states.
RNA-seq enabled transcriptome-wide detection of splice junctions, exon usage, and differential splicing events.
Long-read transcript sequencing improved full-length isoform reconstruction and the interpretation of complex splicing patterns.
Single-cell transcriptomics began revealing cell-type-specific splicing programs and isoform diversity across individual cells.
AI increasingly supports splice variant prediction, isoform annotation, disease mechanism discovery, and therapeutic splicing research.
Continue exploring the Transcriptomics Research Center.
Continue exploring the Transcriptomics Research Center.
Continue exploring the Transcriptomics Research Center.